KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Revenue (2019 - 2025)

Historic Revenue for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $196.0 million.

  • GoodRx Holdings' Revenue rose 39.79% to $196.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $800.7 million, marking a year-over-year increase of 129.89%. This contributed to the annual value of $792.3 million for FY2024, which is 560.59% up from last year.
  • Latest data reveals that GoodRx Holdings reported Revenue of $196.0 million as of Q3 2025, which was up 39.79% from $203.1 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Revenue ranged from a high of $213.3 million in Q4 2021 and a low of $160.4 million during Q1 2021
  • Moreover, its 5-year median value for Revenue was $195.3 million (2024), whereas its average is $192.5 million.
  • Per our database at Business Quant, GoodRx Holdings' Revenue skyrocketed by 4326.21% in 2021 and then crashed by 1366.76% in 2022.
  • GoodRx Holdings' Revenue (Quarter) stood at $213.3 million in 2021, then decreased by 13.67% to $184.1 million in 2022, then rose by 6.81% to $196.6 million in 2023, then rose by 0.99% to $198.6 million in 2024, then fell by 1.29% to $196.0 million in 2025.
  • Its last three reported values are $196.0 million in Q3 2025, $203.1 million for Q2 2025, and $203.0 million during Q1 2025.